[1] Zhou J, Chen J, Wei Q, et al. The role of ischemia reperfusion injury in early hepatic allograft dysfunction[J]. Liver Transpl, 2020, 26: 1034-1048. [2] Tokodai K, Lannsjö C, Kjaernet F, et al. Association of post-reperfusion syndrome and ischemia-reperfusion injury with acute kidney injury after liver transplantation[J]. Acta Anaesthesiol Scand, 2020, 64: 742-750. [3] 周云松, 温晓辉, 杨林西, 等. 骨桥蛋白反义核酸抑制乳腺癌细胞系增殖和诱导其凋亡[J]. 基础医学与临床, 2009, 29: 850-854. [4] Si J, Wang C, Zhang D, et al. Osteopontin in bone metabolism and bone dseases[J]. Med Sci Monit, 2020, 26: e919159. doi: 10.12659/MSM.919159. [5] Song Z, Chen W, Athavale D, et al. Osteopontin takes center stage in chronic liver disease[J]. Hepatology, 2021, 73: 1594-1608. [6] Cui G, Chen J, Wu Z, et al. Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis[J]. J Cell Physiol, 2019, 234: 8988-8997. [7] Varalshmi B, Kiranmyai VS, Aparna B, et al. Plasma osteopontin levels in patients with acute kidney injury requiring dialysis: a study in a tertiary care institute in South India[J]. Int Urol Nephrol, 2020, 52: 917-921. [8] 杨媛淇, 刘川, 杨杰, 等. 急性高原暴露人群血清骨桥蛋白水平与肺动脉收缩压的相关性研究[J]. 中华心血管病杂志, 2020, 48: 489-494. [9] 苟毅, 余天雾, 黄中荣, 等. 白藜芦醇对大鼠肝缺血再灌注损伤的保护作用及其与Sirt1-p53通路的关系[J]. 第三军医大学学报, 2017, 39: 1366-1370. [10] Chen Y, Li T, Tan P, et al. Kaempferol from penthorum chinense pursh attenuates hepatic ischemia/reperfusion injury by suppressing oxidative stress and inflammation through activation of the Nrf2/HO-1 signaling pathway[J]. Front Pharmacol, 2022, 13: 857015. doi: 10.3389/fphar.2022.857015. [11] 李伟涛, 翟淑萍, 苑伟, 等.白细胞介素-1、细胞间黏附分子-1、核因子-κB在大鼠肝缺血再灌注损伤中的作用及其机制[J]. 中华实验外科杂志, 2018, 35: 1253-1255. [12] Larsson A, Helmersson-Karlqvist J, Lind L, et al. Strong associations between plasma osteopontin and several inflammatory chemokines, cytokines, and growth factors[J]. Biomedicines, 2021, 9: 908. doi:10.3390/biomedicines9080908. |